Previous close | 1.5400 |
Open | 1.4700 |
Bid | 1.5000 x 3000 |
Ask | 1.5400 x 1200 |
Day's range | 1.4600 - 1.5800 |
52-week range | 0.6000 - 1.8800 |
Volume | 272,752 |
Avg. volume | 130,003 |
Market cap | 10.625M |
Beta (5Y monthly) | 1.34 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1760 |
Earnings date | 11-Feb-2021 - 15-Feb-2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 29-Sep-1989 |
1y target est | 2.35 |
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $291,000 (a loss of $0.04 per fully diluted share) for its first fiscal quarter ended September 30, 2020 compared to a loss of $143,000, (a loss of $0.02 per fully diluted share) for the quarter ended September 30, 2019. Net loss for the quarter ended September 30, 2020 was $340,000 (a loss of $0.05 per fully diluted share) compared to a net loss of $261,000 ($0.04 per fully diluted share) for the quarter ended September 30, 2019.
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $600,000 (a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2020 compared to a loss of $1,143,000, (a loss of $0.16 per fully diluted share) for the quarter ended June 30, 2019. Net loss for the quarter ended June 30, 2020 was $679,000 (a loss of $0.10 per fully diluted share) compared to a net loss of $2,221,000 ($0.32 per fully diluted share) for the quarter ended June 30, 2019.
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its share repurchase program terminated pursuant to its terms on June 1, 2020. The program was previously suspended on March 24, 2020, due to uncertainly relating to the COVID-19 pandemic.